Zofran News
Dr. Reddy's posts strong Q4 net on generics sales - Reuters India
... strong quarterly profit, well above forecasts, on sales of generics such as a cheap rival to GlaxoSmithKline Plc.'s anti-nausea blockbuster, Zofran. ...
INTERVIEW-Dr Reddy's says 2007/08 profit to fall - Reuters
N: Quote, Profile, Research blockbuster Zofran and revenue of about $370 million from authorised generics, Prasad said. "Revenue will fall especially when ...
INTERVIEW - Dr Reddy's says 2007/08 profit to fall - Reuters India
So net profit will be a lower number. "We had a good run in all our businesses. Of course, our biggest earner was the Zofran 180-day exclusivity."
Dr. Reddy's Posts Strong Q4 Net on Generics Sales - Reuters.uk
The fiscal year that ended in March saw one-time gains from a 180-day exclusivity period for Zofran's generic equivalent, and authorized generics. ...
The Doctor Is on a Roller Coaster - MSNBC
Sales of the generic version of GlaxoSmithKline's (NYSE: GSK) antinausea tablet Zofran also helped with increased sales, since this quarter included most of ...
Dr Reddy’s logs Rs 325-crore net profit in Q4 - Economic Times
The company launched ondansetron, generic version of Zofran, in the end of December 2006 with 180-day exclusivity, which has contributed Rs 290 crore and ...
Back in the black: Dr Reddy’s posts Rs325 cr profit for Q4 - Livemint
Dr Reddy’s began selling its copy of GlaxoSmithKline Plc.’s nausea antidote Zofran in the US in December without other generic competition for 180 days. ...
Dr Reddy’s likely to post Q4 PAT at Rs 878mn: Motilal Oswal - Moneycontrol.com
Zofran) are expected to grow by 56% YoY to Rs 10.9 billion and PAT (excl. Zofran) to Rs 878 million (v/s losses of Rs 232 million). ...
Glaxo Profit Was Little Changed on Lower Drug Sales (Update4) - Bloomberg
The company also lost patent protection on the allergy spray Flonase, antidepressant Wellbutrin XL and nausea drug Zofran, medicines that brought in 554 ...
Zofran RSS Feed